Summer Road’s Ocular Therapeutix OCUL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$129M Buy
13,887,468
+9,450
+0.1% +$87.7K 98.23% 1
2025
Q1
$102M Buy
13,878,018
+8,550
+0.1% +$62.7K 98.23% 1
2024
Q4
$118M Sell
13,869,468
-528,725
-4% -$4.52M 98.61% 1
2024
Q3
$125M Sell
14,398,193
-487,440
-3% -$4.24M 98.66% 1
2024
Q2
$102M Buy
14,885,633
+525,000
+4% +$3.59M 98.54% 1
2024
Q1
$131M Buy
14,360,633
+6,700,083
+87% +$61M 100% 1
2023
Q4
$34.2M Buy
7,660,550
+1,538,461
+25% +$6.86M 100% 1
2023
Q3
$19.2M Hold
6,122,089
100% 1
2023
Q2
$31.6M Hold
6,122,089
100% 1
2023
Q1
$32.3M Hold
6,122,089
100% 1
2022
Q4
$17.2M Buy
6,122,089
+27,328
+0.4% +$76.8K 100% 1
2022
Q3
$25.3M Buy
6,094,761
+150,000
+3% +$622K 100% 1
2022
Q2
$23.9M Hold
5,944,761
100% 1
2022
Q1
$29.4M Buy
5,944,761
+180,000
+3% +$891K 100% 1
2021
Q4
$40.2M Buy
5,764,761
+145,900
+3% +$1.02M 100% 1
2021
Q3
$56.2M Hold
5,618,861
100% 1
2021
Q2
$79.7M Hold
5,618,861
100% 1
2021
Q1
$92.2M Hold
5,618,861
100% 1
2020
Q4
$116M Buy
5,618,861
+437
+0% +$9.05K 100% 1
2020
Q3
$42.8M Hold
5,618,424
100% 1
2020
Q2
$46.8M Buy
5,618,424
+363,636
+7% +$3.03M 100% 1
2020
Q1
$26M Buy
5,254,788
+1,450,000
+38% +$7.18M 99.63% 1
2019
Q4
$15M Hold
3,804,788
99.32% 1
2019
Q3
$11.6M Hold
3,804,788
57.21% 1
2019
Q2
$16.7M Hold
3,804,788
51.37% 1
2019
Q1
$15.1M Buy
3,804,788
+19,938
+0.5% +$79.2K 43.34% 1
2018
Q4
$15.1M Buy
3,784,850
+757,362
+25% +$3.01M 62.56% 1
2018
Q3
$20.8M Hold
3,027,488
68.81% 1
2018
Q2
$20.4M Hold
3,027,488
67.96% 1
2018
Q1
$19.7M Buy
+3,027,488
New +$19.7M 67.84% 1